Neogenomics (NEO) FCF Margin Growth (3y) (2013 - 2026)
Neogenomics (NEO) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 221.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -682.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3,227.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -891.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 175.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 819.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 896.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 327.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 23.00 |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn | 1,198.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,198.00 |
| Mar 31, 2026 | 945.00 |
| Dec 31, 2025 | 249.00 |
| Sep 30, 2025 | 1,903.00 |
| Jun 30, 2025 | 2,954.00 |
| Mar 31, 2025 | 1,405.00 |
| Dec 31, 2024 | 2,422.00 |
| Sep 30, 2024 | 1,782.00 |
| Jun 30, 2024 | 1,917.00 |
| Mar 31, 2024 | -837.00 |
| Dec 31, 2023 | 1,128.00 |
| Sep 30, 2023 | -59.00 |
| Jun 30, 2023 | -254.00 |
| Mar 31, 2023 | -550.00 |
| Dec 31, 2022 | -338.00 |
| Sep 30, 2022 | -2,954.00 |
| Jun 30, 2022 | -1,379.00 |
| Mar 31, 2022 | -3,483.00 |
| Dec 31, 2021 | -4,126.00 |
| Sep 30, 2021 | -2,776.00 |